Tradestie Institutional Equity Comparison Engine

INDS vs NURE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NURE Overall Edge

NURE Captures Institutional Edge (1โ€“0 Pillars ยท 1โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nuveen Short-Term REIT ETF (NURE) driven by superior Momentum & Technical. Fundamentally, INDS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus NURE at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, INDS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NURE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
INDS N/M vs NURE N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner NURE
1Y +6.5% vs +16.7% ยท 52W Pos 57% vs 86%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
INDS NYSE Arca
Pacer Industrial Real Estate ETF
Institutional Equity
$39.99
-0.23% 1D
Market Cap N/A
1M Return +5.56%
1Y Return +6.51%
Forward P/E N/M
Unified AI Score
40.7 / 100 SELL
Tech 43.0 Fund 45.0 Flow 50.0 Mom 50.0
NURE Cboe BZX
Nuveen Short-Term REIT ETF
Institutional Equity
$32.53
+0.42% 1D
Market Cap N/A
1M Return +6.38%
1Y Return +16.73%
Forward P/E N/M
Unified AI Score
33.6 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INDS +6.51% NURE +16.73% Spread: +10.22 pp (NURE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
INDS TTM Op. Margin: N/A NURE TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INDS vs NURE. Trailing 12-month operating profitability (INDS N/A vs NURE N/A) and valuation multiples (INDS N/M vs NURE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INDS (2) vs NURE (1)
Institutional Metric INDS NURE Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 57% ($36โ€“$43) 86% ($27โ€“$33) Stronger Trend NURE
Beta / 30D Volatility Risk Regime 0.42ฮฒ ยท 17% Vol 0.26ฮฒ ยท 18% Vol Lower Realized Risk INDS
Unified Institutional Score Composite Signal 40.7 / 100 (SELL) 33.6 / 100 (SELL) Higher Composite INDS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INDS vs NURE Buy Guide
INDS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live INDS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NURE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NURE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INDS nor NURE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.